Gary Coronado/Los Angeles Times via Getty Images Summary Following my coverage of L’Oreal (OTCPK:LRLCF) last October, for which I recommended a buy rating as the business continued to grow robustly across its product range and operating regions, this post is to provide an update on my thoughts on the business and stock. I believe my…
JulPo Visa (NYSE:V) reported Q1 FY24 earnings that exceeded market expectations on January 25 after the market close. In my introductory article published last October, I highlighted their double-digit earnings growth and strong cross-border recovery. I remain confident in Visa’s overall strength in the global payment network and reiterate a ‘Strong Buy’ rating with a…
Yuichiro Chino/Moment via Getty Images The US is eating the world. Earlier this week, Goldman Sachs reported that the domestic stock market now comprises a record 64% of the global equity arena. I put this to X, and the response suggested trepidation among individual investors. The case was made that some mean reversion could be…
alexsl Zoom’s (NASDAQ:ZM) business, although performing with slow momentum, continues to outpace investor expectations. For FY 2024, Zoom management now expects to generate about $4,495 billion in sales and $1,743 billion in operating earnings. And while the new calendar year is unlikely to bring a pivot in Zoom’s organic growth trajectory, there is little indication…
Vladimir Zapletin Since I gave Ternium S.A. (NYSE:TX) a buy rating in May, the stock is down about 2% largely due to falling steel prices and missing its Q3 EPS target. However, steel prices are bottoming, the company is growing market share in both Mexico and Brazil, and EPS is projected to rise by almost…
mesh cube/iStock via Getty Images On April 2023 we initiated on Rambus (NASDAQ:RMBS) with a buy rating. Our thesis was supported first by the A.I. revolution and by the massive shift to DDR5 memory. Since our initiation, the stock has generated a 20.69 % alpha against the S&P. In this article, we will dive through…
SimonSkafar Summary In my previous coverage (in May’23), I recommended a buy rating as I saw a path for AGCO (NYSE:AGCO) earnings and revenue to continue growing, supported by the strong industry tailwind. I also believed that management FY23 revised sales guidance was management signaling higher volume. Since my last update, the stock performed as…
Jitalia17 The Treasury term premium is back above zero. This is often a tough concept to grasp for casual investors. The term premium in yields is defined as the a bond’s yield minus the expected average short rates (over the life of the bond), and the term premium in forward rates is defined as forward…
Flashpop/DigitalVision via Getty Images Airbnb, Inc. (NASDAQ:ABNB) stock continues to trade at rich valuations as Wall Street is too focused on the impressive profit margins. ABNB has benefitted from organic search traffic, giving it a sizable boost to profitability relative to other online travel agencies. ABNB has a significant net cash position, again in stark…
Ethan Miller Investment Thesis With the continuing negative sentiment surrounding Qualcomm (NASDAQ:QCOM), I wanted to take a look at what investors are fearing the most about the company’s outlook and how I think that the company will be able to survive the short-term noise and will reward patient shareholders in the long run. I covered…
Michele Ursi/iStock via Getty Images At the beginning of summer, I raised the Teucrium Wheat ETF (NYSEARCA:WEAT) to a buy based on the potential negative impact of a developing El Niño, as well as rising geopolitical tensions between Ukraine and Russia. So far, my upgrade appears to be miss-timed, as the WEAT ETF had a…
sturti/E+ via Getty Images Investment Thesis In continuation with the coverage of Yatsen Holding (NYSE:YSG), we had ascribed a Buy rating on the back of a recovery in Chinese consumer spends, strong growth in its skincare pivot and turnaround of its Perfect Diary (PD) brand. We had ascribed a taIt has continued to report improving…
eyecrave productions/E+ via Getty Images Investment Thesis In continuation with our coverage of Primo Water (NYSE:PRMW), we rated PRMW as Buy, driven by its transformational journey over the past few years, robust and improved operational profile, and relative undervaluation. The stock has outperformed significantly, clocking over 19% gains in the last 2 months compared to…
David_Bokuchava/iStock Editorial via Getty Images Investment Thesis In continuing with our coverage for Dufry (OTCPK:DUFRY), we had assigned a buy rating to the stock for a play on long term passenger growth driven by robust travel demand, particularly from China, along with relative undervaluation compared to pre-pandemic levels. We also are constructive as the overhang…
Matteo Colombo Investment Updates The price risk in Mesa Laboratories, Inc. (NASDAQ:MLAB) equity stock remains well in situ despite a balanced set of Q1 FY’24 numbers, and a turn off its 52-week lows in the last few months. Since my June publication on MLAB the major headwinds to it rating back to previous highs remain…
Matteo Colombo Investment Briefing In my June publication covering Integra LifeSciences Holdings Corporation (NASDAQ:IART) I outlined the case to how it was not an investment-grade company based on a number of outcomes at its Boston manufacturing facility. I’ll re-hash the salient points on this today but the fact is multiple uncertainties remain on the company’s…
Edwin Tan Archer-Daniels-Midland Company (NYSE:ADM) procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States and internationally. We have started coverage on the firm in July 2022, with a hold rating. Since then, the stock has gained about 18%, slightly outperforming the broader market, which has gone up by roughly…
Pgiam/iStock via Getty Images Investment briefing Following its latest set of numbers the investment case for Quipt Home Medical Corp. (NASDAQ:QIPT) has only ripened further in my opinion. Since my April publication the company has sold off with a c.$3/share correction. The price line is now wedging up, setting higher lows after closing higher on…
DragonImages/iStock via Getty Images Summary Following my coverage of Rover Group (NASDAQ:ROVR), I recommended a buy rating due to my view that ROVR was still undervalued back then. The stock has done fantastically well over the past few months, and the recent earnings have caused another gap up to a high of $7 (my target…
sturti Summary Following my coverage on Randstad (OTCPK:RANJF), which I recommended a hold rating until there is an improvement in the overall operating environment. This post is to provide an update on my thoughts on the business and stock. I reiterate my hold rating as I await the next 2 quarters to confirm the trend…
Sean Anthony Eddy Investment action I recommended a buy rating for Conmed (NYSE:CNMD) when I wrote about it the last time, as I was positive on the revised guidance, which reflected recovering share dynamics following the disruption early in 2023 and improvements in procedure volumes and staffing. Based on my current outlook and analysis of…